Filter
597
Filtered Results: 597
Text search:
pharmacovigilance
Featured
Recommendations
63
New Publications
163
Language
Document type
No document type
268
Guidelines
123
Studies & Reports
85
Strategic & Response Plan
41
Manuals
35
Fact sheets
17
Training Material
9
Resource Platforms
8
Situation Updates
4
Online Courses
4
Infographics
2
Videos
1
Countries / Regions
Kenya
26
Global
19
Ghana
18
Congo, Democratic Republic of
18
South Africa
17
India
17
Uganda
16
Nigeria
15
Western and Central Europe
14
Namibia
13
Rwanda
12
Senegal
12
Eastern Europe
12
Ethiopia
12
Nepal
10
Latin America and the Carribbean
10
West and Central Africa
9
Zambia
9
Sierra Leone
8
Burkina Faso
8
Malawi
8
Tanzania
8
East and Southern Africa
8
Madagascar
8
Africa
7
Benin
6
Haiti
6
South–East Asia Region
6
Philippines
5
Cambodia
5
Bangladesh
5
Russia
5
Botswana
5
Liberia
5
Middle East and North Africa
4
Ukraine
3
Lesotho
3
Cameroon
3
Zimbabwe
3
Mozambique
3
Eastern Europe and Central Asia
3
Chile
2
Syria
2
Burundi
2
Morocco
2
Guinea
2
Asia
2
Paraguay
2
Lebanon
2
Brazil
2
Sudan
2
Mali
2
Chad
2
Libya
2
Indonesia
2
Myanmar / Burma
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Gambia
1
Togo
1
Laos
1
Afghanistan
1
Jordan
1
Western Pacific Region
1
France
1
Maldives
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Argentina
1
Vietnam
1
Sri Lanka
1
Yemen
1
Georgia
1
Central African Republic
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
300
Clinical Guidelines
59
Public Health
15
Pharmacy & Technologies
11
Capacity Building
9
Women & Child Health
8
Key Resources
7
Toolboxes
Pharmacy
72
COVID-19
62
TB
55
AMR
47
Malaria
41
NTDs
27
HIV
24
Rapid Response
6
Ebola & Marburg
6
Caregiver
5
Planetary Health
5
NCDs
4
Refugee
3
Specific Hazards
2
Global Health Education
2
Cholera
1
Conflict
1
Zika
1
Polio
1
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
The "Primary Healthcare Standard Treatment Guidelines and Essential Medicines List" by the South African National Department of Health provides evidence-based guidelines for diagnosing and managing common medical conditions at the primary healthcare level. This document includes treatment protocols ...
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively reach its 51 million population, most of whom battle tuberculosis, acute respiratory infections, diar...
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified health care provider and do not receive the necessary care in a...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
WHO Guidelines for the Treatment of Human African Trypanosomiasis. Web Annex B
The toolkit is a collection of assessment tools and checklists that describe the key considerations to be taken into account when transitioning to Option B/B+. The toolkit provides a roadmap to support the planning and implementation of Option B/B+, and to help countries scale up more effective inte...
The WHO Cholera Vaccine Position Paper (August 2017) highlights the importance of oral cholera vaccines (OCVs) as a key tool in outbreak response and prevention, alongside water, sanitation, and hygiene (WASH) measures. It recommends OCVs for high-risk populations, endemic areas, and humanitarian cr...
This annual report gives an overview of WHO lesotho Country office's undertakings and achievements in the context of an extraordinary health emergency. As we walk another mile this year, may we embrace all lessonst leanred in the previous year, learn from what did not work so well and take on new op...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existing socio-economic and health-related conditions, resources, regulatory structures and processes and out...
This document provides a decision-making framework for implementation of mass treatment interventions, active case-finding campaigns and population-based surveys for neglected tropical diseases in the context of the COVID-19 pandemic. A two-step approach is proposed: a risk–benefit assessment, to ...
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t...
